PUMA BIOTECHNOLOGY, INC. Increase (Decrease) in Inventories
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Increase (Decrease) in Inventories of $7.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $4.63M.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $3.18M, a 11670.37% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$3.96M, a 165.46% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $885.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in inventories for fiscal 2025 was -$3.21M, a 295.19% decline from fiscal 2024.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in inventories for fiscal 2024 was $1.64M, a 35.63% decline from fiscal 2023.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in inventories for fiscal 2023 was $2.55M.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in inventories for fiscal 2022 was -$2.58M, a 170.67% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.81M 10-Q · filed 2026-08-06 | $3.85M derived: sum of 3 quarters · filed 2026-08-06 | $4.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.18M 10-Q · filed 2026-05-07 | -$783.00K derived: sum of 2 quarters · filed 2026-05-07 | $102.00K derived: sum of 3 quarters · filed 2026-05-07 | -$58.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.08M derived: sum of 2 quarters · filed 2026-02-26 | -$3.24M derived: sum of 3 quarters · filed 2026-08-06 | -$3.21M 10-K · filed 2026-02-26 |
| 2025-09-30 | $885.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $725.00K derived: sum of 2 quarters · filed 2026-08-06 | $752.00K 10-Q · filed 2025-11-06 | $6.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$160.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$133.00K 10-Q · filed 2026-08-06 | $5.92M derived: sum of 3 quarters · filed 2026-08-06 | -$458.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $27.00K 10-Q · filed 2026-05-07 | $6.08M derived: sum of 2 quarters · filed 2026-05-07 | -$298.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.65M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$325.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.62M derived: sum of 3 quarters · filed 2026-02-26 | $1.64M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$4.43M derived: sum of 2 quarters · filed 2025-11-06 | -$4.41M 10-Q · filed 2025-11-06 | -$3.01M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.97M 10-Q · filed 2025-08-07 | $3.37M derived: sum of 3 quarters · filed 2026-02-26 | $1.42M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $20.00K 10-Q · filed 2025-05-08 | $1.42M derived: sum of 2 quarters · filed 2026-02-26 | -$531.00K derived: sum of 3 quarters · filed 2026-02-26 | $3.21M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$551.00K derived: sum of 2 quarters · filed 2026-02-26 | $3.19M derived: sum of 3 quarters · filed 2026-02-26 | $2.55M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.79M derived: sum of 2 quarters · filed 2024-11-07 | $1.15M 10-Q · filed 2024-11-07 | $227.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $3.10M 10-Q · filed 2024-08-01 | $2.18M derived: sum of 3 quarters · filed 2025-02-27 | $966.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$635.00K 10-Q · filed 2024-05-02 | -$1.56M derived: sum of 2 quarters · filed 2025-02-27 | -$2.77M derived: sum of 3 quarters · filed 2025-02-27 | -$3.39M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$926.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$2.14M derived: sum of 2 quarters · filed 2025-02-27 | -$2.75M derived: sum of 3 quarters · filed 2025-02-27 | -$2.58M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.82M derived: sum of 2 quarters · filed 2023-11-02 | -$1.66M 10-Q · filed 2023-11-02 | -$1.75M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$612.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$444.00K 10-Q · filed 2023-08-03 | -$541.00K derived: sum of 3 quarters · filed 2024-02-29 | -$955.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $168.00K 10-Q · filed 2023-05-04 | $71.00K derived: sum of 2 quarters · filed 2024-02-29 | -$343.00K derived: sum of 3 quarters · filed 2024-02-29 | -$468.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$511.00K derived: sum of 2 quarters · filed 2024-02-29 | -$636.00K derived: sum of 3 quarters · filed 2024-02-29 | $3.65M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$414.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$539.00K derived: sum of 2 quarters · filed 2022-11-03 | $3.75M 10-Q · filed 2022-11-03 | $4.06M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.17M 10-Q · filed 2022-08-04 | $4.48M derived: sum of 3 quarters · filed 2023-03-02 | $4.73M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $4.29M 10-Q · filed 2022-05-05 | $4.60M derived: sum of 2 quarters · filed 2023-03-02 | $4.85M derived: sum of 3 quarters · filed 2023-03-02 | $4.45M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $563.00K derived: sum of 2 quarters · filed 2023-03-02 | $157.00K derived: sum of 3 quarters · filed 2023-03-02 | $284.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $253.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$153.00K derived: sum of 2 quarters · filed 2021-11-04 | -$26.00K 10-Q · filed 2021-11-04 | $21.00K derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | -$406.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$279.00K 10-Q · filed 2021-08-05 | -$232.00K derived: sum of 3 quarters · filed 2022-03-03 | -$369.00K derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | $127.00K 10-Q · filed 2021-05-06 | $174.00K derived: sum of 2 quarters · filed 2022-03-03 | $37.00K derived: sum of 3 quarters · filed 2022-03-03 | $660.00K derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$90.00K derived: sum of 2 quarters · filed 2022-03-03 | $533.00K derived: sum of 3 quarters · filed 2022-03-03 | $545.00K 10-K · filed 2022-03-03 |
| 2019-09-30 | -$137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $486.00K derived: sum of 2 quarters · filed 2020-11-05 | $498.00K 10-Q · filed 2020-11-05 | $291.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $623.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $635.00K 10-Q · filed 2020-08-06 | $428.00K derived: sum of 3 quarters · filed 2021-03-01 | $785.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $12.00K 10-Q · filed 2020-05-07 | -$195.00K derived: sum of 2 quarters · filed 2021-03-01 | $162.00K derived: sum of 3 quarters · filed 2021-03-01 | -$105.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $150.00K derived: sum of 2 quarters · filed 2021-03-01 | -$117.00K derived: sum of 3 quarters · filed 2021-03-01 | $596.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $357.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $90.00K derived: sum of 2 quarters · filed 2019-11-07 | $803.00K 10-Q · filed 2019-11-07 | $2.74M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $446.00K 10-Q · filed 2019-08-09 | $2.39M derived: sum of 3 quarters · filed 2020-02-28 | |
| 2018-03-31 | $713.00K 10-Q · filed 2019-05-10 | $2.65M derived: sum of 2 quarters · filed 2020-02-28 | ||
| 2017-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $2.03M 10-K · filed 2020-02-28 | ||
| 2017-09-30 | $89.00K 10-Q · filed 2018-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |